Insider · CIK 0001618670
Tiago Girao
Files at IMVT (Immunovant, Inc.). First filing Apr 24, 2026, latest Jul 24, 2026.
In brief
Tiago Girao files SEC Form 4 as CFO at IMVT (Immunovant, Inc.). Since Apr 24, 2026, Tiago Girao has reported 0 open-market buys worth $0 and 3 open-market sells worth $1.4M, the latest filed on Jul 24, 2026.
A track record needs three past buys with six months of prices behind them; Tiago Girao has 0, so none is measured yet.
The newest scored trade: sold $263k of IMVT on Jul 23, 2026, filed Jul 24, 2026, scored 50 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $1.4M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Immunovant, Inc. | $263k 6,798 shares | -3% | +168% from low-4% from high | |
| 38Weak | Immunovant, Inc. | $385k 10,000 shares | -4% | +164% from low0% from high | |
| 59Moderate | Immunovant, Inc. | $763k 25,760 shares | -9% | +110% from low-2% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 26, 2026 | IMVT IMMUNOVANT, INC. | 10,000 0.00% of outstanding | $385k | Jun 26, 2026 | none |
Transactions
Every row this insider has filed, 9 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 23, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -6,798 | $38.69 | $263k | 240,798 | Jul 24, 2026 |
| Jun 26, 2026 | IMVT Immunovant, Inc. | MOption exercise Common Stock | +10,000 | $15.90 | $159k | 257,596 | Jun 26, 2026 |
| Jun 26, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -10,000 | $38.46 | $385k | 247,596 | Jun 26, 2026 |
| Jun 26, 2026 | IMVT Immunovant, Inc. | MOption exercise Stock Option (right to buy)derivative | -10,000 | $0.00 | $0 | 283,505 | Jun 26, 2026 |
| Apr 23, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -25,760 | $29.62 | $763k | 247,596 | Apr 24, 2026 |
| Apr 7, 2026 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +64,968 | $0.00 | $0 | 273,356 | Apr 9, 2026 |
| Apr 7, 2026 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +94,002 | $0.00 | $0 | 94,002 | Apr 9, 2026 |
| May 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +208,388 | $0.00 | $0 | 208,388 | May 5, 2025 |
| May 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +293,505 | $0.00 | $0 | 293,505 | May 5, 2025 |
Questions about Tiago Girao
Answered from the filings on this page, as of the latest one.
Is Tiago Girao buying or selling?
In the last 12 months Tiago Girao reported 0 open-market buys worth $0 and 3 open-market sells worth $1.4M on SEC Form 4; the latest was sold $263k of IMVT on Jul 23, 2026. Grants, option exercises and tax withholding are not counted.
How did Tiago Girao's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tiago Girao has 0.
Where does Tiago Girao file Form 4?
Tiago Girao has filed Form 4 at IMVT (Immunovant, Inc.) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.